Polku Therapeutics is a small molecule drugs manufacturer for neurodegenerative diseases founded in 2023 by Simon Bennett, Sebastian Soidinsalo, Timo Myöhänen and Docent Erik Wallén.
Currently, there are no issues on this topic. Create one.